In order to investigate in vivo whether pharmacological inhibition of the exosomal secretory pathway could prevent the striatal degeneration observed in HD chimeric mice, we used the drug fingolimod (FTY720), a functional antagonist of sphingosine 1-phosphate receptors that blocks cargo sorting into exosomes [28, 29]. This evidence concerns the gene S1PR1 and Huntington disease.